Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Porcu, Pierluigi
Item TypeName
Concept Lymphoma
Concept Lymphoma, Follicular
Concept Lymphoma, Non-Hodgkin
Concept Leukemia-Lymphoma, Adult T-Cell
Concept Lymphoma, B-Cell
Concept Lymphoma, T-Cell
Concept Lymphoma, Large B-Cell, Diffuse
Concept Lymphoma, T-Cell, Cutaneous
Concept Lymphoma, T-Cell, Peripheral
Concept Lymphoma, AIDS-Related
Concept Lymphoma, B-Cell, Marginal Zone
Concept Lymphoma, Mantle-Cell
Concept Precursor Cell Lymphoblastic Leukemia-Lymphoma
Concept Lymphoma, Extranodal NK-T-Cell
Academic Article Non-Hodgkin's lymphomas.
Academic Article Non-Hodgkin's Lymphomas, version 3.2012.
Academic Article Non-Hodgkin's lymphomas, version 1.2013.
Academic Article A look at the National Comprehensive Cancer Network guidelines for cutaneous lymphomas.
Academic Article Diffuse Large B-Cell Lymphoma Version 1.2016.
Academic Article A phase 2 study of rituximab in combination with recombinant interleukin-2 for rituximab-refractory indolent non-Hodgkin's lymphoma.
Academic Article Fine-needle aspiration biopsy of non-Hodgkin lymphoma for use in expression microarray analysis.
Academic Article The state of cutaneous lymphomas: a call to action.
Academic Article Specific tumor suppressor function for E2F2 in Myc-induced T cell lymphomagenesis.
Academic Article CD4+ CD56+ haematodermic tumour (plasmacytoid dendritic cell neoplasm).
Academic Article A phase 1/1b study of rituximab, bendamustine, and ibrutinib in patients with untreated and relapsed/refractory non-Hodgkin lymphoma.
Academic Article Multicenter phase II trial of enzastaurin in patients with relapsed or refractory advanced cutaneous T-cell lymphoma.
Academic Article Periocular cutaneous anaplastic large cell lymphoma clearance with brentuximab vedotin.
Academic Article Non-Hodgkin's lymphomas, version 4.2014.
Academic Article Phase 2 trial of rituximab and bortezomib in patients with relapsed or refractory mantle cell and follicular lymphoma.
Academic Article Cutaneous marginal zone B-cell lymphoma in the setting of fluoxetine therapy: a hypothesis regarding pathogenesis based on in vitro suppression of T-cell-proliferative response.
Academic Article Combination immunotherapy of B-cell non-Hodgkin's lymphoma with rituximab and interleukin-2: a preclinical and phase I study.
Academic Article We should have a dream: unlocking the workings of the genome in cutaneous T-cell lymphomas.
Academic Article A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype.
Academic Article Chronic lymphocytic leukemia/small lymphocytic lymphoma, version 1.2015.
Academic Article Primary Cutaneous B-Cell Lymphoma: Management and Patterns of Recurrence at the Multimodality Cutaneous Lymphoma Clinic of The Ohio State University.
Academic Article Non-Hodgkin's lymphomas.
Academic Article A phase I/II dose escalation study of apolizumab (Hu1D10) using a stepped-up dosing schedule in patients with chronic lymphocytic leukemia and acute leukemia.
Academic Article Results of a phase II study of 506U78 in cutaneous T-cell lymphoma and peripheral T-cell lymphoma: CALGB 59901.
Academic Article NCCN Guidelines Insights: Non-Hodgkin's Lymphomas, Version 3.2016.
Academic Article Non-Hodgkin's lymphoma. Clinical practice guidelines in oncology.
Academic Article Automated kappa and lambda light chain mRNA expression for the assessment of B-cell clonality in cutaneous B-cell infiltrates: its utility and diagnostic application.
Academic Article Epstein-Barr virus- and human herpesvirus 8-associated primary cutaneous plasmablastic lymphoma in the setting of renal transplantation.
Academic Article Evolving insights in the pathogenesis and therapy of cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome).
Academic Article New targets of therapy in T-cell lymphomas.
Academic Article Prolonged myelosuppression with clofarabine in the treatment of patients with relapsed or refractory, aggressive non-Hodgkin lymphoma.
Academic Article Combination bortezomib and rituximab treatment affects multiple survival and death pathways to promote apoptosis in mantle cell lymphoma.
Academic Article High-dose therapy and autologous stem cell transplantation for follicular lymphoma undergoing transformation to diffuse large B-cell lymphoma.
Academic Article Mechanism, Consequences, and Therapeutic Targeting of Abnormal IL15 Signaling in Cutaneous T-cell Lymphoma.
Academic Article Flavopiridol, fludarabine, and rituximab in mantle cell lymphoma and indolent B-cell lymphoproliferative disorders.
Academic Article Extranodal Marginal Zone Lymphoma-like Presentations of Angioimmunoblastic T-Cell Lymphoma: A T-Cell Lymphoma Masquerading as a B-Cell Lymphoproliferative Disorder.
Academic Article Flavopiridol can be safely administered using a pharmacologically derived schedule and demonstrates activity in relapsed and refractory non-Hodgkin's lymphoma.
Academic Article Allogeneic stem cell transplantation for patients with relapsed chemorefractory aggressive non-hodgkin lymphomas.
Academic Article Complex karyotype is associated with aggressive disease and shortened progression-free survival in patients with newly diagnosed mantle cell lymphoma.
Academic Article Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model.
Academic Article A phase 1 trial of the HDAC inhibitor AR-42 in patients with multiple myeloma and T- and B-cell lymphomas.
Academic Article AIDS-associated malignancies.
Academic Article Non-Hodgkin's lymphomas, version 2.2014.
Academic Article A positive randomised trial in cutaneous T-cell lymphoma.
Academic Article Sézary syndrome: immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC).
Academic Article Complete response to induction therapy in patients with Myc-positive and double-hit non-Hodgkin lymphoma is associated with prolonged progression-free survival.
Academic Article Epstein--Barr virus-associated B-cell lymphoma in the setting of iatrogenic immune dysregulation presenting initially in the skin.
Academic Article NCCN Clinical Practice Guidelines in Oncology: non-Hodgkin's lymphomas.
Academic Article Extranodal NK/T Cell Lymphoma, Nasal Type (ENKTL-NT): An Update on Epidemiology, Clinical Presentation, and Natural History in North American and European Cases.
Academic Article Durable hematologic complete response and suppression of HTLV-1 viral load following alemtuzumab in zidovudine/IFN-{alpha}-refractory adult T-cell leukemia.
Academic Article The combination of milatuzumab, a humanized anti-CD74 antibody, and veltuzumab, a humanized anti-CD20 antibody, demonstrates activity in patients with relapsed and refractory B-cell non-Hodgkin lymphoma.
Academic Article Autologous transplantation as consolidation for aggressive non-Hodgkin's lymphoma.
Academic Article Increased Levels of Plasma Epstein Barr Virus DNA Identify a Poor-Risk Subset of Patients With Advanced Stage Cutaneous T-Cell Lymphoma.
Academic Article Systemic therapy for cutaneous T-cell lymphoma: who, when, what, and why?
Academic Article Treating cutaneous T-cell lymphoma with highly irregular surfaces with photon irradiation using rice as tissue compensator.
Academic Article Activity of the PI3K-d,? inhibitor duvelisib in a phase 1 trial and preclinical models of T-cell lymphoma.
Academic Article Diminished microRNA-29b level is associated with BRD4-mediated activation of oncogenes in cutaneous T-cell lymphoma.
Academic Article Pilot trial of ibrutinib in patients with relapsed or refractory T-cell lymphoma.
Academic Article Primary CD20+CD10+CD8+ T-cell lymphoma of the skin with IgH and TCR beta gene rearrangement.
Academic Article Highly cytotoxic natural killer cells are associated with poor prognosis in patients with cutaneous T-cell lymphoma.
Academic Article Duvelisib, an oral dual PI3K-d,? inhibitor, shows clinical and pharmacodynamic activity in chronic lymphocytic leukemia and small lymphocytic lymphoma in a phase 1 study.
Academic Article Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial.
Academic Article Experimental treatment of Epstein-Barr virus-associated primary central nervous system lymphoma.
Academic Article Editorial: Murine Models of Leukemia and Lymphoma.
Academic Article Early CTCL diagnosis, a (miR)age no more?
Academic Article Feasibility of allogeneic hematopoietic stem cell transplantation for follicular lymphoma undergoing transformation to diffuse large B-cell lymphoma.
Academic Article Autologous transplantation as consolidation for high risk aggressive T-cell non-Hodgkin lymphoma: a SWOG 9704 intergroup trial subgroup analysis.
Academic Article Overview of the Use of Murine Models in Leukemia and Lymphoma Research.
Academic Article Sézary Syndrome: Clinical and Biological Aspects.
Academic Article Targeting the Bcl-2 Family in B Cell Lymphoma.
Academic Article Expanding and expounding the genomic map of CTCL.
Academic Article The Role of an Integrated Multidisciplinary Clinic in the Management of Patients with Cutaneous Lymphoma.
Academic Article Peripheral T-Cell Lymphoma, not Otherwise Specified (PTCL-NOS).
Academic Article Frequency and clinical correlates of elevated plasma Epstein-Barr virus DNA at diagnosis in peripheral T-cell lymphomas.
Academic Article Cutaneous mantle cell lymphoma: a clinicopathologic review of 10 cases.
Academic Article Emerging insights on the pathogenesis and treatment of extranodal NK/T cell lymphomas (ENKTL).
Academic Article Preclinical Targeting of MicroRNA-214 in Cutaneous T-cell Lymphoma (CTCL).
Academic Article The absence of CD20 messenger RNA in recurrent cutaneous B-cell lymphoma following rituximab therapy.
Academic Article Emerging insights on the biology and treatment of cutaneous T-cell lymphoma.
Academic Article Cutaneous CD4+ CD56+ hematologic malignancies.
Academic Article Primary cutaneous CD30+ large cell B-cell lymphoma: a series of 10 cases.
Academic Article Systemic therapy of cutaneous T-cell lymphoma (CTCL).
Academic Article Mogamulizumab versus investigator choice in relapsed/refractory adult T-cell leukemia/lymphoma: all four one or none for all?
Academic Article IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label, phase 1 trial.
Academic Article Recent Advances in Cutaneous T-cell Lymphoma: Diagnostic and Prognostic Considerations.
Academic Article Extreme Peripheral Blood Plasmacytosis Mimicking Plasma Cell Leukemia as a Presenting Feature of Angioimmunoblastic T-Cell Lymphoma (AITL).
Academic Article Romidepsin Plus Liposomal Doxorubicin Is Safe and Effective in Patients with Relapsed or Refractory T-Cell Lymphoma: Results of a Phase I Dose-Escalation Study.
Academic Article A phase 1 study of vorinostat maintenance after autologous transplant in high-risk lymphoma.
Academic Article Clinical Features Predictive of Survival in Patients With Vitreoretinal Lymphoma: Analysis of 70 Patients at a Single Ocular Oncology Center.
Academic Article Improved outcomes for extranodal natural killer T-cell lymphoma.
Academic Article Quality of Life Effect of the Anti-CCR4 Monoclonal Antibody Mogamulizumab Versus Vorinostat in Patients With Cutaneous T-cell Lymphoma.
Academic Article Relapsed Splenic Lymphoma Mimicking Recurrent Pyelonephritis.
Academic Article Phase I/II study of bendamustine in combination with ofatumumab, carboplatin, etoposide (BOCE) for relapsed or refractory aggressive B-cell non-Hodgkin lymphoma.
Academic Article Gemcitabine and bendamustine is a safe and effective salvage regimen for patients with recurrent/refractory Hodgkin lymphoma: Results of a phase 1/2 study.
Academic Article Clinical characteristics and outcomes of black patients with mycosis fungoides and Sézary syndrome: a subgroup analysis of the phase III MAVORIC trial.
Academic Article Autologous EBV-specific T cell treatment results in sustained responses in patients with advanced extranodal NK/T lymphoma: results of a multicenter study.
Academic Article Lack of impact of type and extent of prior therapy on outcomes of mogamulizumab therapy in patients with cutaneous T cell lymphoma in the MAVORIC trial.
Academic Article Profiling is a good thing (at least in the clinic).
Search Criteria
  • Lymphoma